Is Calcitonin at 6-12 Months an Appropriate Criterion to Define Cure in Medullary Thyroid Carcinoma?
Where this comes from
- Record sourced from PubMed, PMID 42541766.
- Also identified by DOI 10.1002/wjs.70477.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Current recommendations from the American Thyroid Association define undetectable calcitonin (Ct) at 6-12 months after surgery as biochemical cure in medullary thyroid carcinoma (MTC). This criterion has also been used in some studies to assess the risk of recurrence. However, this definition may not accurately reflect disease behavior as some patients with early biochemical persistence later normalize Ct, whereas others never develop structural disease.